4/28
05:33 pm
tbph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
Neutral
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
4/27
07:00 pm
tbph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
4/26
10:00 am
tbph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
4/25
10:00 am
tbph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
4/24
10:42 am
tbph
Laughing Water Capital's New Position: Theravance Biopharma, Inc. (TBPH) [Yahoo! Finance]
Low
Report
Laughing Water Capital's New Position: Theravance Biopharma, Inc. (TBPH) [Yahoo! Finance]
4/24
10:00 am
tbph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
4/23
10:57 am
tbph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
4/21
04:40 pm
tbph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
4/19
08:23 pm
tbph
B. Riley Lifts PT on Theravance Biopharma (TBPH) to $17 From $14 [Yahoo! Finance]
Low
Report
B. Riley Lifts PT on Theravance Biopharma (TBPH) to $17 From $14 [Yahoo! Finance]
4/16
11:38 pm
tbph
Theravance Stock Declines Around 17% in Three Months: Here's Why [Yahoo! Finance]
Low
Report
Theravance Stock Declines Around 17% in Three Months: Here's Why [Yahoo! Finance]
4/16
10:00 am
tbph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
4/16
09:00 am
tbph
TBPH Guided for $75M in Milestones While Trial Risk Went Unquantified -- LEVI & KORSINSKY, LLP
Low
Report
TBPH Guided for $75M in Milestones While Trial Risk Went Unquantified -- LEVI & KORSINSKY, LLP
4/15
09:00 am
tbph
TBPH: Reported $22M in Operating Expenses While Advancing Trial Enrollment -- LEVI & KORSINSKY, LLP Investigates
Low
Report
TBPH: Reported $22M in Operating Expenses While Advancing Trial Enrollment -- LEVI & KORSINSKY, LLP Investigates
4/14
05:03 pm
tbph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
4/14
01:00 am
tbph
Low
Report
4/11
06:15 pm
tbph
Theravance Biopharma (TBPH) was downgraded by
Weiss Ratings from "buy (b-)" to "hold (c+)".
Low
Report
Theravance Biopharma (TBPH) was downgraded by
Weiss Ratings from "buy (b-)" to "hold (c+)".
4/9
10:00 am
tbph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
4/8
10:31 am
tbph
TBPH Investors Have Opportunity to Join Theravance Biopharma, Inc. Fraud Investigation with the Schall Law Firm
Low
Report
TBPH Investors Have Opportunity to Join Theravance Biopharma, Inc. Fraud Investigation with the Schall Law Firm
4/7
12:51 pm
tbph
Theravance Biopharma (TBPH) had its price target raised by B. Riley Financial, Inc. from $14.00 to $17.00. They now have a "neutral" rating on the stock.
Low
Report
Theravance Biopharma (TBPH) had its price target raised by B. Riley Financial, Inc. from $14.00 to $17.00. They now have a "neutral" rating on the stock.
4/6
01:06 am
tbph
Medium
Report
4/2
08:48 pm
tbph
TBPH Investors Have Opportunity to Join Theravance Biopharma, Inc. Fraud Investigation with the Schall Law Firm
Medium
Report
TBPH Investors Have Opportunity to Join Theravance Biopharma, Inc. Fraud Investigation with the Schall Law Firm
4/1
09:00 am
tbph
TBPH: Reported $22M in Operating Expenses While Advancing Trial Enrollment -- LEVI & KORSINSKY, LLP Investigates
Low
Report
TBPH: Reported $22M in Operating Expenses While Advancing Trial Enrollment -- LEVI & KORSINSKY, LLP Investigates
3/29
01:09 am
tbph
Low
Report
3/26
09:00 am
tbph
TBPH Guided for $75M in Milestones While Trial Risk Went Unquantified -- LEVI & KORSINSKY, LLP
Low
Report
TBPH Guided for $75M in Milestones While Trial Risk Went Unquantified -- LEVI & KORSINSKY, LLP
3/25
06:13 pm
tbph
Theravance Biopharma (TBPH) was upgraded by
Weiss Ratings from "hold (c)" to "buy (b-)".
Low
Report
Theravance Biopharma (TBPH) was upgraded by
Weiss Ratings from "hold (c)" to "buy (b-)".